Lexeo Therapeutics, Inc. (LXEO) KPIs and segments
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.85−0.38 (-11.61%)
Close on Nov 17, 2026Market cap $234.24MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Lexeo Therapeutics's business
Coming soon
This tab will track the numbers specific to Lexeo Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?